EUVIMEDEUVIMED entdecken
Crossref

Evaluation of the Use of Steroid-Sparing Immunosuppressants in Dermatological Disorders: Prescription Pattern and Safety Considerations

Sanglaap Saha, Romit Banerjee, Ritarshi Bhattacharya, Soumik Ghosh, Ranita Das, Suhena Sarkar, Abanti Saha, Amrita Sil

International Journal of Current Pharmaceutical Review and Research · 30.04.2026 · 18 (04)

DOI: 10.25258/ijcpr.18.4.8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.04.2026. Verfasst von Sanglaap Saha und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic dermatological conditions including psoriasis, lupus, vitiligo, pemphigus, and lichen planus frequently require systemic immunosuppressive therapy. Long-term corticosteroids carry significant morbidity, prompting reliance on steroid-sparing immunosuppressants. Prospective real-world data on their prescription patterns and safety profiles from tertiary care dermatology centres in India remain limited.

Objectives

To evaluate the prescription patterns and incidence of adverse drug reactions (ADRs) of steroidsparing immunosuppressants in patients with chronic dermatological disorders attending a tertiary care centre.

Methods

A prospective, cross-sectional observational study was conducted over six months in the Dermatology OPD and IPD of a tertiary care medical college in eastern India. A total of 183 adult patients receiving non-steroidal immunosuppressants for at least four weeks were enrolled. Socio-demographic, clinical, and pharmacological data were recorded using structured case report forms. ADRs were documented using the CDSCO ADR reporting form version 1.4 and causality assessed by the WHO-UMC scale.

Results

The mean age was 39.22 ± 16.13 years; 53% were female. Psoriasis was the most prevalent diagnosis (47.4%), followed by vitiligo (14.1%) and lupus (6.0%). Methotrexate was the most frequently prescribed agent (27.3%), followed by tacrolimus (11.5%), tofacitinib (10.9%), and cyclosporine (15.8%). The ADRs encountered were mostly mild to moderate in severity with 26.4% systemic effects and 5.1% for mucocutaneous effects. Dyslipidaemia, cough, and arthralgia were the most common systemic ADRs (3.8% each). All ADRs were mild to moderate in severity.

Conclusion

Methotrexate followed by cyclosporine dominated steroid sparing immunosuppressant prescriptions, consistent with national and international literature. The ADR profile was predominantly mild to moderate. Regular monitoring and pharmacovigilance are essential to ensure safe long-term use of these agents in dermatology practice.

Zitieren

APA

Saha, S., Banerjee, R., Bhattacharya, R., Ghosh, S., Das, R., Sarkar, S., Saha, A., & Sil, A. (2026). Evaluation of the Use of Steroid-Sparing Immunosuppressants in Dermatological Disorders: Prescription Pattern and Safety Considerations. International Journal of Current Pharmaceutical Review and Research, 18(04). https://doi.org/10.25258/ijcpr.18.4.8

Vancouver

Saha S, Banerjee R, Bhattacharya R, Ghosh S, Das R, Sarkar S, et al. Evaluation of the Use of Steroid-Sparing Immunosuppressants in Dermatological Disorders: Prescription Pattern and Safety Considerations. International Journal of Current Pharmaceutical Review and Research. 2026;18(04). doi:10.25258/ijcpr.18.4.8

BibTeX
@article{Saha2026,
  author = {Saha, Sanglaap and Banerjee, Romit and Bhattacharya, Ritarshi and Ghosh, Soumik and Das, Ranita and Sarkar, Suhena and Saha, Abanti and Sil, Amrita},
  title = {Evaluation of the Use of Steroid-Sparing Immunosuppressants in Dermatological Disorders: Prescription Pattern and Safety Considerations},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {04},
  doi = {10.25258/ijcpr.18.4.8}
}
Kostenlos starten →